hydralazine has been researched along with gallopamil in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aloamaka, CP; Ebeigbe, AB | 1 |
Pang, CC; Sutter, MC | 1 |
Diamond, J; Shaikh, MI | 1 |
Fehér, J; Gachályi, B; Juhász, I; Székács, B | 1 |
4 other study(ies) available for hydralazine and gallopamil
Article | Year |
---|---|
Mechanism of hydralazine-induced relaxation of arterial smooth muscle.
Topics: Animals; Barium; Barium Compounds; Calcium; Calcium Chloride; Chlorides; Dose-Response Relationship, Drug; Gallopamil; Hydralazine; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Norepinephrine; Potassium Chloride; Rats; Serotonin | 1985 |
Chronic treatment of rats with D-600 causes a compensatory decrease in the calcium requirement for contractility of vascular smooth and cardiac muscles.
Topics: Animals; Blood Pressure; Calcium; Gallopamil; Heart Rate; Hydralazine; In Vitro Techniques; Isoproterenol; Male; Muscle Contraction; Muscle, Smooth, Vascular; Myocardial Contraction; Norepinephrine; Portal Vein; Potassium; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Verapamil | 1985 |
Effects of hydralazine and D-600 on KCl induced contraction and phosphorylase activation in rabbit aorta.
Topics: Animals; Aorta; Drug Interactions; Enzyme Activation; Gallopamil; Hydralazine; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Phosphorylases; Potassium Chloride; Rabbits; Verapamil | 1980 |
TxA2-PGI2-PGF2 alfa responses in the kidney to blood pressure reduction induced by vasodilator/vasorelaxing agents with different action in patients with essential hypertension.
Topics: Adolescent; Adult; Blood Pressure; Dinoprost; Epoprostenol; Female; Gallopamil; Glomerular Filtration Rate; Humans; Hydralazine; Hypertension; Kidney; Male; Middle Aged; Prazosin; Prostaglandins; Sodium; Thromboxane A2; Vasodilator Agents; Venous Pressure | 1993 |